Literature DB >> 596926

Gentamicin dosage in preterm and term neonates.

B M Assael, V Gianni, A Marini, P Peneff, F Sereni.   

Abstract

Pre-dose and peak serum levels of gentamicin were measured in 82 neonates (25-42 weeks' gestational age), and for comparison in 10 infants and 9 children. Dosage was 2-2.5 mg/kg twice daily for the neonates, and three times daily for infants and children. Neonates were subdivided according to gestational age and weight. Serum levels of gentamicin were very variable in all groups. Preterm neonates of low gestational age (25-30 weeks) showed a 66% incidence of pre-dose levels exceeding 1 microgram/ml, indicating possible accumulation. In the less premature neonates this incidence was still 20-29%. The level of 4 microgram/ml, the minimum concentration required to inhibit most of the bacteria sensitive to gentamicin, was reached in increasing numbers of neonates as their gestational age rose (from 30% in the 31- to 35-week gestational age group, to 60% at term); those small-for-gestational age had consistently lower levels. It is concluded that term neonates require dosage to be individualized and serum levels of the drug to be monitored.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596926      PMCID: PMC1544809          DOI: 10.1136/adc.52.11.883

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Renal function as a marker of human fetal maturation.

Authors:  S R Siegel; W Oh
Journal:  Acta Paediatr Scand       Date:  1976-07

2.  Gentamicin dosage in children.

Authors:  M Taylor; C Keane
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

3.  Gentamicin in the neonatal period.

Authors:  G H McCracken; L G Jones
Journal:  Am J Dis Child       Date:  1970-12

Review 4.  Body composition in intrauterine growth retardation.

Authors:  G Cassady
Journal:  Pediatr Clin North Am       Date:  1970-02       Impact factor: 3.278

5.  The current status of gentamicin for tne neonate and young infant.

Authors:  J D Nelson; G H McCracken
Journal:  Am J Dis Child       Date:  1972-07

6.  Aspects of pharmacology of gentamicin in newborn infants.

Authors:  J B Andersen; N Rosdahl; R Vejlsgaard
Journal:  Acta Paediatr Scand       Date:  1972-05

7.  Kanamycin and gentamicin treatment of neonatal sepsis and meningitis.

Authors:  M J Chang; M Escobedo; D C Anderson; L Hillman; R D Feigin
Journal:  Pediatrics       Date:  1975-11       Impact factor: 7.124

8.  Aspects of the pharmacology of gentamicin during the neonatal period.

Authors:  N Rosdahl; J B Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973

9.  Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.

Authors:  M I Marks; R Prentice; R Swarson; E K Cotton; T C Eickhoff
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

10.  Age-dependent dose response to gentamicin.

Authors:  P Echeverria; G R Siber; J Paisley; A L Smith; D H Smith; N Jaffe; D Paed
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

View more
  12 in total

1.  A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants.

Authors:  M English; S Mohammed; A Ross; S Ndirangu; G Kokwaro; F Shann; K Marsh
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

2.  Bayesian pharmacokinetic analysis of a gentamicin nomogram in neonates: a retrospective study.

Authors:  Robert E Ariano; Daniel S Sitar; Maria Davi; Sheryl A Zelenitsky
Journal:  Curr Ther Res Clin Exp       Date:  2003-03

Review 3.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

4.  Incidence of potentially toxic concentrations of gentamicin in the neonate.

Authors:  A Mulhall; J de Louvois; R Hurley
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

5.  Pharmacokinetics of gentamicin in very low birth weight preterm infants.

Authors:  K W Hindmarsh; R L Nation; G L Williams; E John; J N French
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

7.  Serum levels of ampicillin and gentamycin in neonates of varying gestational age.

Authors:  L B Dahl; K Melby; T J Gutteberg; G Størvold
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

Review 8.  Time course of trough serum gentamicin concentrations in preterm and term neonates.

Authors:  M A de Cos; J Gómez-Ullate; F Gómez; J A Armijo
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

9.  Estimation of gentamicin clearance and volume of distribution in neonates and young children.

Authors:  A W Kelman; A H Thomson; B Whiting; S M Bryson; D A Steedman; G E Mawer; L A Samba-Donga
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

10.  Continuous intravenous infusion of ampicillin and gentamicin during parenteral nutrition in 88 newborn infants.

Authors:  H Colding; S Møller; G E Andersen
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.